1. NOTE B14 Advanced Materials
  2. NOTE B15 Advanced Formulations
  3. NOTE B16 Performance Chemicals
  4. NOTE B17 Corporate & Business Services

Segment overview

in € million

 

2017

 

2016

 

% yoy

(1)

CFROI (Cash Flow Return On Investment) and Research & Innovation reference figures are provided on a non-restated basis.

Net sales

 

10,125

 

9,569

 

5.8%

Advanced Materials

 

4,370

 

4,313

 

1.3%

Advanced Formulations

 

2,966

 

2,668

 

11%

Performance Chemicals

 

2,766

 

2,581

 

7.2%

Corporate & Business Services

 

23

 

7

 

n.m.

EBITDA

 

2,230

 

2,075

 

7.5%

Advanced Materials

 

1,202

 

1,110

 

8.2%

Advanced Formulations

 

524

 

484

 

8.1%

Performance Chemicals

 

749

 

718

 

4.3%

Corporate & Business Services

 

(244)

 

(237)

 

(2.8)%

EBIT

 

1,527

 

1,403

 

8.8%

Advanced Materials

 

896

 

829

 

8.1%

Advanced Formulations

 

374

 

327

 

14%

Performance Chemicals

 

566

 

549

 

3.0%

Corporate & Business Services

 

(308)

 

(301)

 

(2.4)%

Capex from continuing operations

 

(716)

 

(839)

 

15%

Advanced Materials

 

(366)

 

(435)

 

16%

Advanced Formulations

 

(130)

 

(134)

 

3.0%

Performance Chemicals

 

(152)

 

(191)

 

20%

Corporate & Business Services

 

(68)

 

(79)

 

14%

Research & innovation(1)

 

(325)

 

(350)

 

(7.0)%

Advanced Materials

 

(157)

 

(155)

 

(1.5)%

Advanced Formulations

 

(85)

 

(87)

 

2.1%

Performance Chemicals

 

(29)

 

(26)

 

(10)%

Corporate & Business Services

 

(55)

 

(52)

 

(4.5)%